Abstract:Objective: To analyze the risk factors of percutaneous coronary intervention (PCI) no-reflow in patients with coronary heart disease (CHD) and construct a predictive nomogram model. Methods: This retrospective study included 260 patients with CHD who underwent PCI in the Third Affiliated Hospital of Chongqing Medical University from January 2022 to December 2023. The subjects were divided into a PCI no-reflow group (n = 86) and normal reflow group (n = 174) based on thrombolysis in myocardial infarction (TIMI) blood flow grading. General data, PCI related data and laboratory indexes of patients were collected. Logistic regression was used to analyze the risk factors of no-reflow after PCI in CHD patients. Based on the significant variables from regression analysis, a nomogram prediction model was constructed by using R language. The accuracy of the model was evaluated by receiver operating characteristic (ROC) curve and calibration curve, and the decision curve was drawn to clarify the clinical utility of the model. Model performance metrics included area under the curve (AUC), accuracy, sensitivity and specificity. Results: Multivariate logistic regression analysis showed that hypertension, cystatin C (Cys-C), hypersensitive c-reactive protein (hs-CRP) and platelet-to-lymphocyte ratio (PLR) were risk factors for no-reflow after PCI in CHD patients (OR > 1, P < 0.001), while ADAM metallopeptidase with thrombospondin type 1 motif 13 (ADAMTS-13) and lymphocyte (LYM) were protective factors (OR < 1, P < 0.001). The nomogram prediction model based on the above risk factors showed good predictive value. The AUC of the nomogram prediction model in the training set was 0.967 (95% CI: 0.946-0.989), with a specificity of 0.923 and a sensitivity of 0.908. In the validation set, the AUC was 0.894 (95% CI: 0.817-0.971), with a specificity of 0.807 and a sensitivity of 0.857. The calibration curve indicated good agreement between the predicted and actual probabilities, and the decision curve showed clinical benefit across a range of threshold probabilities in both the training and validation sets (0.0-0.99). Conclusion: The risk factors affecting the occurrence of no-reflow after PCI in patients with CHD include hypertension, serum Cys-C, hs-CRP, PLR, ADAMTS-13 and LYM levels. The nomogram risk prediction model based on the above factors is valuable for identifying patients with high risk of no-reflow after PCI.

A potential role for the CDH13/CDH15 gene in repeat revascularization after first percutaneous coronary intervention.

A potential role for the <i>CDH13</i>/<i>CDH15</i> gene in repeat revascularization after first percutaneous coronary intervention

Clinical Outcomes and Risk Factors of Coronary Artery Aneurysms after Successful Percutaneous Coronary Intervention and Drug-Eluting Stent Implantation for Chronic Total Occlusions

Predictors of Recurrent Angina in Patients with No Need for Secondary Revascularization.

Investigation of the Underlying Hub Genes and Mechanisms of Reperfusion Injury in Patients Undergoing Coronary Artery Bypass Graft Surgery by Integrated Bioinformatic Analyses.

Candidate Gene of NOS3, MMP3, AGT, and AGT1R and Pathway Analyses for Platelet Reactivity and Clinical Outcomes of Repeat Revascularization After First PCI in Chinese Patients

High-density lipoprotein-related inflammatory indices predict repeat revascularization in coronary drug-eluting stenting

Triglyceride to High-Density Lipoprotein Cholesterol Ratio As a Risk Factor of Repeat Revascularization among Patients with Acute Coronary Syndrome after First-Time Percutaneous Coronary Intervention.

Potential of Immune-Related Genes As Promising Biomarkers for Premature Coronary Heart Disease Through High Throughput Sequencing and Integrated Bioinformatics Analysis.

A Simple Model to Predict Repeat Revascularization After Drug-Eluting Stent Implantation in Patients With Stable Coronary Artery Disease

Analysis of risk factors for PCI no-reflow in coronary heart disease and construction of related prediction models

Polymorphism K469E of Intercellular Adhesion Molecule-1 Gene and Restenosis after Coronary Stenting in Chinese Patients.

Relationship Between ALDH2 Genotype and In-Stent Restenosis in Chinese Han Patients after Percutaneous Coronary Intervention

A Preliminary Study of Association Between the Polymorphism K469E of Intercellular Adhesion Molecule-1 Gene and Restenosis after Coronary Stenting

Mitophagy related diagnostic biomarkers for coronary in-stent restenosis identified using machine learning and bioinformatics

Evaluation of Preprocedural Laboratory Parameters as Predictors of Drug-Eluting Stent Restenosis in Coronary Chronic Total Occlusion Lesions.

The Value of Pregnancy Associated Plasma Protein A and IVS6+95 Gene Polymorphism in Prediction of Restenosis after Percutaneous Coronary Intervention

Effect of NPC1L1 and HMGCR Genetic Variants With Premature Triple-Vessel Coronary Disease

Impact of Subintimal Plaque Modification on Reattempted Chronic Total Occlusions Percutaneous Coronary Intervention.

Heme oxygenase-1 gene promoter polymorphisms are associated with coronary heart disease and restenosis after percutaneous coronary intervention: a meta-analysis

Red Cell Distribution Width in Coronary Heart Disease: Prediction of Restenosis and Its Relationship with Inflammatory Markers and Lipids